CGT9486 (Formerly Known as PLX9486) as a Single Agent and in Combination With PLX3397 (Pexidartinib) or Sunitinib in Participants With Advanced Solid Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Theseus Pharmaceuticals
Novartis
Daiichi Sankyo
National Cancer Institute (NCI)